批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/06/28 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/06/22 |
SUPPL-23(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/11/10 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/03/08 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/09/28 |
SUPPL-9(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2003/07/22 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/07/12 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/10/16 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/06/02 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/08/17 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/02/05 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/04/01 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:BRINZOLAMIDE 剂型/给药途径:SUSPENSION/DROPS;OPHTHALMIC 规格:1% 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020816 |
001 |
NDA |
AZOPT |
BRINZOLAMIDE |
SUSPENSION/DROPS;OPHTHALMIC |
1% |
Prescription |
Yes |
Yes |
AB |
1998/04/01
|
SANDOZ |
209406 |
001 |
ANDA |
BRINZOLAMIDE |
BRINZOLAMIDE |
SUSPENSION/DROPS;OPHTHALMIC |
1% |
Prescription |
No |
No |
AB |
2020/11/27
|
WATSON LABS INC |
204884 |
001 |
ANDA |
BRINZOLAMIDE |
BRINZOLAMIDE |
SUSPENSION/DROPS;OPHTHALMIC |
1% |
Prescription |
No |
No |
AB |
2021/08/18
|
BAUSCH AND LOMB |
211914 |
001 |
ANDA |
BRINZOLAMIDE |
BRINZOLAMIDE |
SUSPENSION/DROPS;OPHTHALMIC |
1% |
Prescription |
No |
No |
AB |
2023/07/28
|
PADAGIS US |